Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mansutti, Mauro"'
Autor:
Gianni, Luca, Colleoni, Marco, Bisagni, Giancarlo, Mansutti, Mauro, Zamagni, Claudio, Del Mastro, Lucia, Zambelli, Stefania, Bianchini, Giampaolo, Frassoldati, Antonio, Maffeis, Ilaria, Valagussa, Pinuccia, Viale, Giuseppe
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
NPJ Breast Cancer
NPJ Breast Cancer
The crosstalk between estrogen and HER2 receptors and cell-cycle regulation sustains resistance to endocrine therapy of HER2- and hormone receptor-positive breast cancer. We earlier reported that women with HER2 and ER-positive breast cancer receivin
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fasola, Gianpiero, Pelizzari, Giacomo, Zara, Diego, Targato, Giada, Petruzzellis, Giuseppe, Minisini, Alessandro Marco, Bin, Alessandra, Donato, Raffaela, Mansutti, Mauro, Comuzzi, Chiara, Candoni, Anna, Sperotto, Alessandra, Fanin, Renato
Publikováno v:
Oncologist; Apr2021, Vol. 26 Issue 4, pe694-e703, 10p, 2 Diagrams, 4 Charts
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fasola, Gianpiero, Aita, Marianna, Marini, Luisa, Follador, Alessandro, Tosolini, Marina, Mattioni, Laura, Mansutti, Mauro, Piga, Andrea, Brusaferro, Silvio, Aprile, Giuseppe
Publikováno v:
BMC Health Services Research; 2008, Vol. 8, Special section p1-8, 8p, 3 Charts, 2 Graphs
Autor:
Grazia Arpino, Fabio Puglisi, Marta Bonotto, Massimo Di Maio, Gianpiero Fasola, Lorenzo Gerratana, S. Moroso, Mauro Mansutti, Sabino De Placido, Donatella Iacono, Monica Milano, Carmine De Angelis, Marika Cinausero, Brigida Stanzione, Alessandro Marco Minisini, Piera Gargiulo
Publikováno v:
The Breast. 31:114-120
Background According to current guidelines, endocrine therapy (ET) is recommended as first-line treatment of luminal-like metastatic breast cancer (MBC), whereas chemotherapy (CT) should be considered in presence of life-threatening disease. In daily
Autor:
Andrea Rocca, Mario D'Andrea, Vito Amoroso, Anna Maria Baldelli, Elisabetta Cretella, Chiara Saggia, Ilaria Spagnoletti, Marcella Montico, Stefania Russo, Rosa Meo, Elena Collovà, Emanuela Vattemi, M. Bari, Eva Dreussi, Ferdinando Riccardi, Umberto Basso, Marika Cinausero, Chiara Zanusso, Michele Medici, Maria Agnese Fabbri, Fabio Puglisi, Donatella Iacono, Lorenzo Gianni, Patrizia Serra, Sara Gagno, Mauro Mansutti, Donata Sartori, Giampietro Gasparini, Laura Foghini, Silvana Saracchini, Erika Cecchin, Paola Biason, Salvatore Bonura, Mario Clerico, Arianna Pellegrino, Ghassan Merkabaoui, Giovanni Benedetti, Giuseppe Toffoli, Paolo Sandri, Federico Innocenti
Currently there are no reliable biomarkers to predict outcome of exemestane treatment. We designed a prospective study to investigate whether constitutive genetic background might affect response to therapy. In a population of 302 advanced breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525271d772d274044f56e73dc9c23201
https://hdl.handle.net/11368/3039679
https://hdl.handle.net/11368/3039679